Hatch Biofund Management

Investment thesis

Hatch Biofund invests in early-stage life science companies developing therapeutics and vaccines, leveraging its ties to the Pennsylvania Biotechnology Center for access to industry expertise and infrastructure.

Focus narrative

Hatch Biofund exclusively invests in private companies that are innovating in the fields of therapeutics and vaccines. The firm is particularly interested in capital-efficient projects with a clear understanding of disease biology and development pathways that promise significant societal value. It invests across all development stages, including seed and Series A rounds.

Value beyond capital

Hatch Biofund adds value to its portfolio companies by providing not only capital but also access to physical lab space, incubation infrastructure, and deep industry expertise through its connections with the Pennsylvania Biotechnology Center and other partners.

Community overview

Hatch Biofund is a life sciences venture capital firm based in the Philadelphia region, established to provide early-stage capital to promising life science companies. It offers access to industry expertise and physical platforms to support the missions of these companies.

Community focus

Hatch Biofund focuses exclusively on private companies developing therapeutics and vaccines for human use. The firm invests across all development stages and in various treatment modalities, including small molecules, cell therapy, and gene therapy, emphasizing capital efficiency and significant societal value.